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ABSTRACT 
 
Endocrine disruptors (EDs) are compounds known to promote transgenerational inheritance of 
adult-onset disease in subsequent generations after maternal exposure during fetal gonadal 
development. This study was designed to establish whether gestational and lactational exposure to 
the plasticizer di(2-ethylhexyl)phthalate (DEHP) at environmental doses promotes transgenerational 
effects on reproductive health in female offspring, as adults, over three generations in the mouse. 
Gestating F0 mouse dams were exposed to 0, 0.05, 5 mg/kg/day DEHP in the diet from 
gestational day 0.5 until the end of lactation. The incidence of adult-onset disease in reproductive 
function was recorded in F1, F2 and F3 female offspring. 
In adult F1 females, DEHP exposure induced reproductive adverse effects with: i) altered 
ovarian follicular dynamics with reduced primordial follicular reserve and a larger growing pre-
antral follicle population, suggesting accelerated follicular recruitment; ii) reduced oocyte quality 
and embryonic developmental competence; iii) dysregulation of the expression profile of a panel of 
selected ovarian and pre-implantation embryonic genes.  F2 and F3 female offspring displayed the 
same altered reproductive morphological phenotype and gene expression profiles as F1, thus 
showing transgenerational transmission of reproductive adverse effects along the female lineage.  
These findings indicate that in mice exposure to DEHP at doses relevant to human exposure 
during gonadal sex determination significantly perturbs the reproductive indices of female adult 
offspring and subsequent generations. Evidence of transgenerational transmission has important 
implications for the reproductive health and fertility of animals and humans, significantly increasing 
the potential biohazards of this toxicant. 
 
Keywords: Di(2-ethylhexyl)phthalate (DEHP), maternal exposure, ovary, reproductive toxicity, 
transgenerational, mouse 
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INTRODUCTION 
 
Phthalates (phthalic acid esters) are plasticizers that are added to polymers, especially PVC, to 
impart softness and flexibility. They are widely used in the manufacture of a broad range of 
consumer goods such as medical devices, clothing, packaging, food containers, personal-care 
products and children’s toys (Kavlock et al., 2002). The most widely used phthalate is di(2-
ethylhexyl) phthalate (DEHP), a hormone-interfering compound. With production of approximately 
one to four million tons per year, DEHP is one of the most widespread environmental contaminants 
worldwide (Akingbemi et al., 2001; McKee et al., 2004). Phthalates do not form strong linkages 
with the polymer, so they can diffuse throughout the matrix and leach into the environment 
(Petersen and Breindahl, 2000; Bosnir et al., 2003). As a result, the general population is widely 
and continuously exposed to them through ingestion, inhalation or dermal absorption. Therefore, 
since phthalates exert endocrine disrupting activity, they arouse significant public health concerns 
(Silva et al., 2004; Wittassek and Angerer, 2008).  
The reproductive system is particularly susceptible to the endocrine disrupting activity of 
phthalates. Adverse effects include reduction in female fertility (Agarwal et al., 1989), litter 
size/viability (Agarwal et al., 1985a; Tyl et al., 1988), sperm density and motility, and increased 
reproductive tract malformations (Agarwal et al., 1985b). Phthalates can cross the placental barrier 
and also pass into breast milk. This poses a significant risk of damage for the developing fetus and 
newborn due to inappropriate effects on hormonal levels which, in turn, can result in permanent 
structural and functional changes (Dostal et al., 1987; Latini et al., 2003). Worryingly, many of the 
reproductive abnormalities derived from developmental exposure only become apparent after 
puberty (long-latency effect), which strongly hinders the development of a cause-and-effect 
relationship. 
Recent studies in various species have demonstrated that pre- and peri-natal exposure to DEHP 
induces reproductive tract abnormalities in male offspring, such as hypospadias, undescended testis, 
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underdeveloped epididymis and seminiferous tubules, and reduced daily sperm production and 
sperm fertilizing ability (Barlow and Foster, 2003; Swan et al., 2005; Pocar et al., 2012a).  In 
females the effects of maternal exposure to DEHP have been less well studied than in males but 
include negative effects on oocyte growth, meiotic maturation, and ovarian function (Lovekamp and 
Davis, 2001; Lovekamp-Swan and Davis, 2003). Our previous studies (Pocar et al., 2012a) indicate 
that in maternally exposed female mice, DEHP induced an imbalance of pituitary-gonadal cross-
talk in adulthood, leading to disruption of estrogen biosynthesis pathways in the gonads. This 
endocrine interference was correlated with impaired oocyte quality and early embryo development.  
Of greatest concern is the fact that adverse effects in the ovary have the potential to aﬀect 
subsequent generation(s) through the female germ cells (Gore et al., 2014). Here a substantial 
distinction has to be made between intergenerational transmission involving direct exposure to the 
environmental factor, and transgenerational effects involving germ-line transmission without direct 
exposure of the affected generation (Skinner, 2008). For an ED to have truly transgenerational 
effects, exposure must occur during development, and the effects need to be detectable in the third 
generation (F3). This is because when a pregnant F0 female is exposed to an ED, besides F1, F2 too 
is directly exposed through the developing germ cells in F1. This makes the F3 generation the first 
generation not directly exposed to the ED (Crews and McLachlan, 2006; Skinner, 2008; Walker and 
Gore, 2011). 
 There are various reports of the ability of different environmental EDs such as bisphenol A 
(BPA – (Salian et al., 2009)), dioxin (Bruner-Tran and Osteen, 2011), vinclozolin (Skinner and 
Anway, 2007; Stouder and Paoloni-Giacobino, 2010), polychlorinated biphenyls (PCBs – (Pocar et 
al., 2012b)), and phthalates (Doyle et al., 2013; Manikkam et al., 2013; Chen et al., 2015) to 
promote transgenerational inheritance.  
An important mechanism for transgenerational transmission of disease as a function of early-
life ED exposure is considered to involve epigenomic reprogramming due to the high plasticity of 
the epigenetic code during development (McLachlan et al., 2001). Therefore, when EDs introduce 
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epigenetic changes during early development, they permanently alter the epigenome in the germ 
line, and these changes can be transmitted to subsequent generations. In contrast, when an ED 
introduces epigenetic changes during adult life, the changes within an individual occur in somatic 
cells and are not permanent or transmitted to subsequent generations (Christensen and Marsit, 2011; 
Skinner, 2014). 
As mentioned before, phthalates have been reported to induce transgenerational reproductive 
dysfunction. However, in these studies phthalates were used at pharmacological doses within a 
plastic compound mixture (Manikkam et al., 2013), or male reproductive dysfunction was recorded 
(Doyle et al., 2013; Chen et al., 2015). Information about transgenerational transmission of disease 
through the female lineage is still lacking.  
Considering our previous results showing that gestational exposure to environmental doses of 
DEHP caused adverse effects in female F1 (Pocar et al., 2012a), in the present study we 
investigated whether these effects were inherited by further generations up to F3 along the female 
lineage. Treatment covering the whole gestational and lactational period was scheduled, so as to 
cover the full time window of female reproductive system development in the mouse, including 
epigenetic DNA reprogramming events in female germ cells (Surani et al., 2008). DEHP dosages 
and the administration with food were chosen for their relevance to human exposure. 
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MATERIALS AND METHODS  
Animals 
Five-week old virgin female CD-1 mice were purchased from Charles River (Calco, Italy) and 
allowed to acclimatize for two weeks. They were maintained in the animal facilities of the Dept. of 
Veterinary Medicine, University of Milan, under controlled conditions (23 ± 1°C, 12h light/dark 
cycle). Standard pellet food (4RF21, Charles River) and tap water were available ad libitum. 
Groups of two or three females were mated with one male overnight and the day of the vaginal plug 
was considered day 0.5 of gestation (day post-coitum - dpc +0.5). The pregnant females were 
randomly assigned to the treatment groups and housed individually in type II cages with stainless 
steel covers and hard wood shavings as bedding. Care and experimental procedures with mice were 
in accordance with Italian national regulations and were approved by the University of Milan’s 
ethics committee. 
 
Treatments and doses 
DEHP (Sigma-Aldrich, Hamburg, Germany) was diluted in commercial sunflower oil and used 
by a specialized company (Altromin, Lage, Germany) to prepare treated chow. Pregnant mice were 
given diets formulated to contain known amounts of DEHP or vehicle from dpc 0 throughout 
lactation until weaning (post-natal day 21 – PND 21). Two or three pregnant mice were randomly 
assigned to the groups, and the experiment was replicated at least three times (total 7-10 
dams/treatment). The exposure period for dams was chosen so as to cover the whole time window 
of reproductive system development in the mouse.  
Specifically, dams received a diet formulated to ensure a mean daily intake of: control group – 
vehicle only; DEHP – 0.05 mg/kg/day and 5 mg/kg/day. The amount of DEHP added to the chow  
to obtain the desired doses was calculated on the basis of the mean daily food intake of CD1 mice, 
previously described (Pocar et al., 2012a). Each batch of diet was tested before use in an accredited 
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laboratory (SGS Laboratory GmbH, Hamburg, Germany). The doses were selected in order to 
overlap the DEHP concentrations reported as environmental exposure in humans (Kavlock et al., 
2002).  
 
Experimental design 
On PND 21 F1 pups in both experimental and control groups were sexed and body weight was 
recorded. Female pups from each litter were housed in separate groups up to sexual maturity (PND 
42), Standard pellet food (Charles River 4RF21) and tap water were available ad libitum.  
To study the potential transmission of DEHP effects over multiple generations, at least seven F1 
females from different litters were randomly selected and naturally mated with CD-1 non-exposed 
males of proven fertility, in order to obtain F2 offspring. At sexual maturity, at least seven F2 
females from different litters were randomly chosen and mated as described for F1. The experiment 
ended when F3 offspring reached adult age (PND 42) (Figure 1). 
To serve as controls, at least seven F1 females from different litters in the vehicle-treated group 
were similarly arranged into breeding pairs as described for experimental groups to produce control 
progeny animals in F2 generation. The same breeding scheme was applied to produce control F3 
generation from F2 control dams. To minimize possible environment effects, experimental and 
control groups were processed identically throughout the whole experiment and litters of the same 
generation were housed together in the same room.  
On PND 42, at least three virgin mice per litter from the experimental and control groups were 
randomly selected in each generation for autopsy. Livers, pituitaries and reproductive organs were 
removed, weighed and either snap-frozen in liquid nitrogen, or formalin-fixed for later analysis. The 
remaining F1, F2 and F3 virgin females were fertilized in vitro as described below.  
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In vitro fertilization and embryo culture 
F1, F2 and F3 virgin females were superovulated by intraperitoneal (i.p.) injection of 3.5 IU 
Folligon (PMSG, Intervet International, Netherlands), followed 48h later by an i.p. injection of 5 IU 
Chorulon (hCG, Intervet). 
Spermatozoa were obtained from the cauda epididymis of untreated male mice. Both cauda 
were dissected out from the body and transferred into 500 μL of Whittingham medium previously 
equilibrated (37°C at 5% CO2 in air). Sperm were passively released into the culture medium by 
puncturing the cauda 3-4 times with a 27G needle and capacitated for 60 min in Whittingham 
medium (37°C at 5% CO2 in air). Fourteen hours post-hCG, cumulus oocyte complexes were 
recovered from oviducts in M2 medium (Sigma-Aldrich). After rinsing in Whittingham medium, 
cumulus-oocyte complexes were inseminated with 2*10
6
 capacitated spermatozoa. Putatively 
fertilized eggs (6h post-insemination) were then transferred to 250 μL drops of M16 medium 
(Sigma-Aldrich), covered with paraffin oil and incubated at 37°C at 5% CO2 in air for another 96h. 
Cleavage and blastocyst rates were recorded respectively 24h and 96h post-insemination. 
 
Histological analysis 
Ovaries from F1, F2 and F3 female offspring were fixed in 10% neutral buffered formalin then 
embedded in paraffin. Specimens were serially sectioned (8 μm), mounted on glass slides and 
stained with hematoxylin and eosin (HE) according to standard procedures. Follicle counts were 
taken as described by Tomic et al. (Tomic et al., 2002). Briefly, a stratified sample consisting of ten 
sections was used to establish the number of different follicle classes per ovary. The sections 
selected from each ovary were randomized and follicles were counted on the whole section. We 
only counted follicles with a visible nucleolus in the oocyte so as to avoid counting them twice. We 
then multiplied the number of follicles in the marked sections by 10 (because every 10th section 
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was analyzed) and then by 8 (to account for section thickness) to obtain the total number in each 
ovary.  
Follicles were classified according to Flaws et al. (Flaws et al., 2001), as i) primordial when 
they contained an intact oocyte surrounded by a one-layer ring of fusiform granulosa cells, ii) pre-
antral if they consisted of an oocyte and one or more layer of cuboidal granulosa cells, iii) antral if 
they contained more than one layer of granulosa cells and an antral space, and iv) end-stage atretic 
if they contained zona pellucida remnants. All sections were evaluated “blind”, by an operator with 
with no knowledge of the treatment group of the animals.  
 
RNA Isolation and reverse-transcription PCR 
Total RNA was isolated from one ovary of all mice undergoing autopsy, using Trizol 
(Invitrogen, Carlsbad, CA) according to the manufacturer’s directions. Total RNA was checked for 
integrity and DNA contamination using an ultraviolet (UV) spectrophotometer and 1.3% agarose 
gel electrophoresis. One μg of total RNA extracted from each sample was used to synthesize the 
cDNA using a SuperScript kit (Invitrogen). The RT reaction was carried out at 42ºC for 1h, and 
terminated by heating at 94ºC for 2 min.  
Polyadenylated [poly(A)+] RNA from pre-implantation blastocysts was extracted using 
Dynabeads mRNA DIRECT kit (Deutsche Dynal, Hamburg, Germany). Briefly, pools of six 
blastocysts were lysed using 50 μL of lysis buffer. After lysis, 10 μL prewashed dynabeads-oligo 
(deoxythymidine) were pipetted into the tube, and poly(A)+ RNAs binding to 
oligo(deoxythymidine) was allowed for 5 min at room temperature. The beads were then separated 
with a Dynal MPC-E magnetic separator and washed twice with 50 μL washing buffer A [10 mmol 
Tris-HCl (pH 8.0), 0.15 mmol LiCl, 1 mmol EDTA, and 0.1% (wt./vol) sodium dodecyl sulfate] 
and three times with 50 μL washing buffer B [10 mmol Tris-HCl (pH 8.0), 0.15 mmol LiCl, and 1 
mmol EDTA]. Poly(A)+ RNAs were then eluted from the beads by incubation in 11 μL 
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diethylpyrocarbonate-treated sterile water at 65°C for 2 min. Aliquots were immediately used for 
RT using the PCR Core Kit (Perkin Elmer, Wellesley, MA), with 2.5 μmol random hexamers to 
obtain the widest array of cDNAs. The RT reaction was carried out in a final volume of 20 μL at 
25°C for 10 min and 42°C for 1h, followed by a denaturation step at 99°C for 5 min and immediate 
cooling on ice.  
Table 1 lists the primers and PCR conditions for the genes. In ovaries specific transcripts were 
chosen for their correlation with: gonadotropin response and steroidogenesis (Fsh-R, Lh-R, Star, 
Cyp17a1, Cyp19a1, Pgr), and oocyte quality and follicle health (Gdf9, Bmp15, Pten). In blastocysts 
specific mRNAs (Oct4, Nanog, Gata3, Cdx-2, Eomes, Lif and Lifr) were selected for their role in 
embryonic development and trophoblast differentiation and implantation.  
For each set of primers, the optimal cycle number at which the transcript was exponentially 
amplified was established by running a linear cycle series and the number of PCR cycles was kept 
within this range. Approximately 1 μL cDNA per sample was used for amplification. The cDNA 
fragments were generated by initial denaturation at 94°C for 3 min. The PCR products were 
separated by electrophoresis on 1.3 % agarose gel and detected under UV light. To normalize 
signals from different RNA samples, Gapdh transcripts were co-amplified as an internal standard.  
Quantitative expression was analyzed with Quantity One software using the Volume Analysis 
Report of Quantity One software (Bio-Rad, Hercules, CA, USA).  
 
Statistical analysis 
All data were analyzed using GraphPad Prism software (GraphPad Software 5.03, San Diego 
CA). Differential gene expression was tested by the D'Agostino and Pearson normality test to 
confirm Gaussian distribution, then examined by one-way ANOVA, with statistical significance at 
P≤0.05. For each primer set each amplification run was performed on treatment groups and 
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corresponding generation-control and replicated at least three times. In order to normalize 
individual responses within replicates treatment effects were expressed as DEHP/control ratio. 
The mean numbers of follicles per ovary were calculated on ovaries from at least five different 
mice. Differences between the means were examined by one-way ANOVA, with statistical 
significance at P≤0.05. When ANOVA gave a significant P value, the Newmann-Keuls’ test was 
used in the post hoc analysis. 
Data for in vitro embryo culture were analyzed by binary logistic regression. Controls were taken 
as the reference group. Experiments were replicated at least three times, and each replicate was 
fitted as a factor. The log likelihood ratio statistic was used to detect between-treatment differences 
and significance was set at P<0.05. 
 
RESULTS 
 
Effect of maternal DEHP exposure on ovarian follicular dynamics 
To examine the effects of maternal exposure to DEHP on folliculogenesis in adult mouse 
ovaries of F1 offspring and subsequent generations, different classes of follicles were scored in 
ovarian tissue sections. Results from F1, F2 and F3 ovaries are shown in figure 2. 
In the F1 generation, ovaries showed significantly altered histology (p≤0.001) in all exposure 
groups compared to the vehicle-treated control lineage. Specific findings were: 1) significantly 
fewer primordial follicles (figure 2A), with respectively about 65% and 30% reductions in the 0.05 
mg/kg/day and 5 mg/kg/d groups;  2) significantly more growing pre-antral follicles (figure 2B), 
with about 40% increases in both dose groups; 3) significantly fewer developing antral follicles 
(figure 2C), with respectively about 35% and 50% reductions in the 0.05 mg/kg/day and 5 mg/kg/d 
groups; 4) a higher incidence of follicle late atresia (figure 2D) in the 0.05  mg/kg/day DEHP group.  
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In F2 and F3 generations, similarly to F1, there was a significantly smaller number of 
primordial follicles together with a larger number of pre-antral follicles in both dose groups 
(p≤0.01) (figures 2A and 2B). Since the F3 generation animals had never been exposed to the 
DEHP, these alterations in follicular dynamics were transgenerationally inherited by F3 female 
descendants. Conversely, in F2 and F3 females there was no change in the number of antral or 
atretic follicles, except for a reduction in antral follicles in F2 of the 0.05 mg/kg/day group (figures 
2C and 2D). Therefore, these effects, limited to F1 and F2, can be attributed to direct exposure to 
DEHP. The total number of follicles was unaffected by treatment in all generations. 
 
In vitro oocyte developmental competence in adult female offspring 
In vitro embryo production from oocytes from F1, F2 and F3 adult offspring is illustrated in 
Table 2. Developmental competence of female gametes was tested on a total of 1463 in vivo 
matured oocytes. The oocytes from the F1 mice of the 0.05 mg/kg/day group produced embryos 
with a significantly lower capacity to complete the first mitotic division and to subsequently reach 
the blastocyst stage than controls and the 5 mg/kg/day group (P<0.05). These results agree with our 
previous findings (Pocar et al., 2012a) and confirm a non-monotonic DEHP dose-response curve on 
oocyte developmental competence of in utero and lactationally exposed female gametes. 
The negative consequences on oocyte developmental competence induced by maternal 
exposure to 0.05 mg/kg/day DEHP were still detectable in the subsequent two generations, pointing 
to transgenerational transmission of the effect. As in F1, the numbers of embryos recovered from 
the F2 and F3 0.05 mg/kg/day groups were significantly lower than controls and the 5 mg/kg/day 
group (P<0.05), with respectively about 30% and 60% reductions in cleavage and blastocyst rates. 
 
Expression of genes related to oocyte and follicular development in the ovaries 
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To investigate the mechanisms by which DEHP affects ovarian physiology, we analyzed the 
effects of exposure on the expression profiles of a panel of genes involved in both steroidogenesis 
and folliculogenesis.  Results from F1, F2 and F3 ovaries are shown in Table 3. 
In F1, maternal exposure to DEHP at 0,05 and 0,5 mg/kg/day significantly down-regulated the 
genes related to gonadotropin response in adult offspring ovaries, in agreement with our previous 
findings (Pocar et al., 2012a). In both DEHP treated groups the expression levels of Fsh-R, Lh-R, 
Cyp19a1 and Pgr in ovaries were significantly lower than in controls. Only the mRNA levels for 
StAR in ovaries of the two DEHP groups and Cyp17a1 in the lower dose group were not affected.  
In subsequent generations no alterations were seen in the expression of genes involved in 
gonadotropin response and steroidogenesis, pointing to a direct effect of maternal exposure to 
DEHP on pituitary-gonadal cross-talk. As regards the transcripts related to folliculogenesis, Gdf9 
was consistently up-regulated in F1 ovaries in all treatment groups (p≤0.001), while Bmp15 and 
Pten were unaffected. This pattern of expression remained unaltered over the two subsequent 
generations. This indicates that gene expression related to folliculogenesis is affected 
transgenerationally in mouse adult ovaries and may explain the altered follicular dynamics and 
oocyte developmental competence observed throughout three generations. 
 
Gene expression profile of pre-implantation blastocysts  
To assess the quality of pre-implantation embryos from oocytes in DEHP-treated groups and to 
gain further information on the molecular bases of transgenerational transmission of adverse effects, 
we analyzed the expression profile of a panel of embryonic key genes in morphologically normal 
blastocysts after in vitro fertilization. Table 4 reports data related to the embryonic generations, thus 
from F2 (donor generation F1) to F4 (donor generation F3). 
Key genes involved in embryonic development were significantly altered in F2 and F3 embryos 
of both the DEHP treated groups compared to controls. This indicates a transgenerational effect of 
the toxicant exposure independently from the dose to which the pregnant F0 females had been 
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exposed. In F2 and F3 embryos DEHP induced significant upregulation of transcript levels for Oct-
4 and Gata3, while down-regulating Nanog. No changes in mRNA levels for these genes were 
detected in F4 compared to controls. 
Expression of the genes related to trophoblast differentiation and implantation was significantly 
affected by DEHP and these effects were transgenerationally transmitted, with some differences 
between genes and DEHP doses. Lif-R expression was upregulated by 0.05 and 5 mg DEHP/kg/day 
in both F2 and F3 generations, and in the 0.5 mg/kg/day embryos even up to F4. Transcripts for 
Cdx2, Eomes and Lif were also upregulated in embryos of the DEHP groups, but surprisingly only 
from the F3 generation onwards. Specifically, Cdx2and Eomes mRNA levels were higher than 
controls in embryos from both DEHP groups, but for Lif only in embryos of the lower dose group. 
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DISCUSSION  
To our knowledge, this is the first comprehensive study reporting that maternal exposure to 
environmentally relevant doses of DEHP have transgenerational adverse effects on ovarian 
physiology and female gamete developmental competence in mice. Specifically, from F1 through 
F3 along the female lineage we observed the transmission of an altered reproductive phenotype 
showing: i) changes in ovarian morphology and functionality; ii) reduced oocyte and 
preimplantation embryo developmental competence; iii) changes in transcript levels for genes 
related to oocyte and follicular development in the ovary and iv) changes in gene expression levels 
for key genes in the blastocysts. 
A number of environmental influences (including EDs) during  the  period  of  developmental 
plasticity promote adverse phenotypes that may be transmitted to subsequent generations and 
beyond through the male and female germ lines (Danchin et al., 2011; Pocar et al., 2012b; Skinner 
et al., 2013). Peri-natal exposure to pharmacological doses of phthalates induces transgenerational 
adult-onset reproductive disorders in both male and female rats (Doyle et al., 2013; Manikkam et 
al., 2013; Chen et al., 2015). However, these studies of phthalates followed the generations along 
the male lineage, while little is known about the effects of ED exposure transmitted to subsequent 
generations by the female germ line. 
A variety of theories have been recently explored to explain the germline transgenerational 
transmission of an adverse phenotype. The role of epigenetic inheritance has attracted increasing 
attention in recent years (Jimenez-Chillaron et al., 2009) despite evidence of extensive 
reprogramming during germ cell formation and zygotic development (Danchin et al., 2011; Drake 
and Seckl, 2011; Aiken and Ozanne, 2014). The first wave of epigenetic reprogramming is driven 
by the female germ line, just after fertilization when the early embryo is transcriptionally and  
translationally quiescent and  the  machinery  that  controls  this  epigenetic remodeling and first 
round of DNA replication is orchestrated solely by the oocyte  (Gawecka et al., 2013).  
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The present study did not specifically investigate the epigenetic status of female offspring and 
their oocytes. However, evidence is emerging that long-term and irreversible alterations in ovarian 
physiology induced by developmental exposure to phthalates may be related to early changes in 
epigenetic control of gene expression (Zama and Uzumcu, 2009; Zama and Uzumcu, 2010; Zhang 
et al., 2013). The high frequency of the morphological phenotype in the ovaries and the highly 
consistent patterns of gene expression profiles amongst individuals and litters over four generations 
observed in our study indicate that genetic DNA sequence mutations are not the most likely cause 
(Barber et al., 2002; Dong et al., 2004).  This enables us to hypothesize that the phenotype observed 
in adulthood may result from epigenetic changes in the germ cells and growing oocytes. Maternal 
exposure to DEHP could thus have prevented the proper erasure, re-establishment, or maintenance 
of epigenetic marks in the oocytes, altering the embryonic epigenome, and subsequently enhancing 
postnatal disease susceptibility.  
This hypothesis is supported by recent work indicating that direct exposure of developing 
ovaries to DEHP, besides inducing sensitive alterations in follicular dynamics, significantly affects 
the methylation machinery in follicles and growing oocytes in vivo and in vitro (Xie et al., 2012; 
Zhang et al., 2014). Further studies are now needed to further clarify the mechanisms of these 
transgenerational effects. 
In considering ovarian function, in the present study follicular distribution was characterized by 
a low proportion of primordial follicles and a reciprocal increase in the percentage of growing pre-
antral follicles in DEHP-exposed animals and subsequent generations. These data are in agreement 
with recent reports that exposure to phthalates either in adult age (Hannon et al., 2014) or early 
post-natally (Zhang et al., 2013) induces primordial follicle depletion and increases the population 
of growing follicles in adult mice and their offspring. Similarly, in utero exposure to MEHP (the 
major DEHP metabolite) also raises the percentage of growing follicles in mice (Moyer and Hixon, 
2012). The present finding of the increased number of growing pre-antral follicles is in good 
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agreement with the concomitant upregulation of Gdf9 transcript levels in affected ovaries. Recent 
studies have in fact shown that giving GDF-9 to neonatal rats increases the number of primary and 
pre-antral follicles and reduces the complement of primordial follicles, collectively suggesting that 
GDF-9 promotes initial recruitment (Vitt et al., 2000).  
According to Beranger et al. (Beranger et al., 2012) the phenotype observed in our study 
strongly suggests that maternal exposure to DEHP accelerates the rate of follicle recruitment, which 
would rapidly exhaust the primordial follicle reserve, leading to early reproductive failure. We did 
not actually see any reduction in fertility in in utero treated mice and subsequent generations, but 
we do have to bear in mind that the animals were mated at an early age (8 weeks), and, depending 
on the strain, reproductive activity in mice does not decline up to 8-12 months of age. It is therefore 
likely that there are still enough follicles in the ovary at the age we investigated to support pubertal 
development and fertility, and ovarian failure due to follicle depletion would be visible only later. 
Furthermore, a slight reduction in fecundity could easily have been masked by the large size of the 
litters, characteristic of the mouse strain employed.  This too calls for further investigation.  
In the present study altered follicular dynamics in the ovary was related to impaired oocyte 
developmental competence, as demonstrated by the reduced ability of in vivo matured oocytes to 
complete the first mitotic division and reach the blastocyst stage after in vitro fertilization. The 
mechanisms of how the phthalates influence pre-implantation development are not yet fully 
understood. We previously postulated that adverse effects in oocyte developmental competence, 
after in utero and peri-natal DEHP exposure, might be related to deregulated steroid homeostasis 
and unbalanced pituitary-gonadal axis crosstalk (Pocar et al., 2012a). However, this is apparently 
limited to F1 gonads, pointing to a direct effect of phthalate exposure. 
 Therefore, to cast more light on transgenerational transmission of the effects on gametes we 
analyzed the transcriptional levels of selected genes in blastocysts from oocytes of treated animals 
and their subsequent generations. Preimplantation embryos in the DEHP groups presented 
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dysregulation of the expression profile for key genes involved in early embryonic differentiation 
and development. Our findings indicate an altered profile of pluripotency factors which may lead to 
changes in the differentiation patterns of extra-embryonic lineages. This is supported on the one 
hand by the concomitant overexpression of Oct4 with the down-regulation of Nanog transcript 
levels, and on the other by the up-regulation of the trophoectoderm differentiation markers Gata3, 
Cdx2 and Eomes. It is recognized that Nanog down-regulation orchestrates the differentiation of 
totipotent embryonic cells into extra-embryonic lineages (Hyslop et al., 2005; Hough et al., 2006), 
and that there is an interconnecting autoregulation loop to maintain totipotency so that, if Oct4 
levels rise above a steady level, Nanog expression is repressed (Pan and Thomson, 2007).  
As regards the trophoectoderm markers, both CDX2 and EOMES are transcription factors 
essential for the specification and maintenance of the trophoectoderm-derived trophoblast lineage 
(Niwa et al., 2005). In addition, GATA3 is expressed only in the trophoblast lineage and is both 
necessary and sufficient to promote trophoblast maturation, regulating the process of morula to 
blastocyst transformation (Ralston et al., 2010).  
Our findings as a whole may provide some insights into both the reduced oocyte developmental 
competence and the transgenerational transmission of adverse effects. Indeed, coordinated 
epigenetic regulation occurred for the correct timing of expression in genes related to lineage 
determination including Oct4, Nanog and Cdx2 (Hattori et al., 2004; Zhang et al., 2008).  
In conclusion, the present study indicates that DEHP administered to pregnant female mice 
induces alterations in the reproductive health of female offspring. Of particular concern is the fact 
that effects were observed up to the third generation, pointing to a transgenerational effect of DEHP 
in female offspring. In all the generations investigated, DEHP altered primordial follicle 
recruitment, and this can potentially interfere with normal ovarian function and cause premature 
ovarian failure (POF). In humans, population-based studies estimate that 1% of women experience 
POF (Coulam et al., 1986; Cramer and Xu, 1996; Luborsky et al., 2003).  It appears too that women 
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occupationally exposed to phthalates during their reproductive life are at greater risk of POF than 
women of reproductive age in other occupations (Gallicchio et al., 2009). Grindler and co-workers 
documented a direct association between phthalate exposure and earlier age at menopause (Grindler 
et al., 2015). The DEHP doses employed were within the range of real environmental exposure in 
humans. Therefore, our observations of the dangerous effects of DEHP on folliculogenesis as 
regards reproductive performance throughout generations give reason for concern. In fact, although 
mouse data must obviously be evaluated very carefully before being extrapolated to the human 
fetus, folliculogenesis processes and blastocyst development are similar and phthalates can cross the 
placenta in both species.  It is therefore reasonable to hypothesize that human fetal DEHP exposure 
during critical points in development might also act on follicular development and ovarian function.  
To gain more information on the potential for POF and infertility in the general population, further 
work is necessary to completely elucidate the mechanism of DEHP-induced acceleration of 
primordial follicle recruitment and the toxic effects on gametes after in utero exposure. 
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FIGURE LEGENDS 
Figure 1 Diagram of the experimental approach with focus on multigenerational and 
transgenerational phenomena and direct exposure of the F0 mother, F1 embryo, and F2 germ-line. 
The F3 generation is the first without direct exposure. (dpc, day post-coitum; pnd, post-natal day) 
 
Figure 2 Distribution of follicular stages in ovaries of the F1, F2 and F3 offspring. A) primordial; 
B) pre-antral; C) antral; D) end-stage atretic. Each column represents the mean ± SE of at least three 
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separate experiments. Asterisks denote significant differences from corresponding generation-
control (** p≤0.001; * p≤0.05). 
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Gene Accession No. Primers 
Annealing 
T° 
Product 
size 
gapdh NM008084 
F: TCACCATCTTCCAGGAGCG 
R: CTGCTTCACCACCTTCTTGA 
57 572 
lhr NM013582 
F: TCTACCTGCTGCTCATTGCCTC 
R: AAGGCAGCTGAGATGGCAAAG 
57 553 
fshr NM013523 
F: ATGTGTAACCTCGCCTTTGCTG 
R: AACATACAGCTGCGACAAAGGG 
57 393 
star BC082283 
F: GAAGGAAAGCCAGCAGGAGAAC 
R: CTGCGATAGGACCTGGTTGATG 
58 496 
cyp17a1 AY594330 
F: ACGGTGGGAGACATCTTTGGG 
R: CCTTCGGGATGGCAAACTCTC 
57 283 
cyp19a1 NM007810 
F: CCTCTGGATACTCTGCGACGAG 
R: CGAATGGTGGAAGTTTGTGTGG 
56 508 
pgr NM008829 
F: GATGAGCCTGATGGTGTTTGGC 
R: GGGCAACTGGGCAGCAATAAC 
57 490 
gdf-9 NM008110 F: GGCACTTCCCAGCAACTTCC 
R: GGTGACTTCTGCTGGGTTTGG 
58 326 
bmp15 NM009757 F: GCAAGGAGATGAAGCAATGGC 
R: GAAGCGGAGGCGAAGAACAC 
57 458 
pten NM008960 F: TGGAAAGGGACGGACTGGTG 
R: CCGCCACTGAACATTGGAATAG 
55 249 
nanog NM028016 F: TGCCAGGAAGCAGAAGATG 
R: TTATGGAGCGGAGCAGCATTC 
57 471 
oct4 NM013633 F: ATCACTCACATCGCCAATCAGC 
R: CAGAGCAGTGACGGGAACAGAG 
58 279 
cdx2 NM007673 
F: GAAACCTGTGCGAGTGGATGC 
R: TGCTGCTGCTGCTTCTTCTTG 
58 265 
eomes  NM001164789 
F: GTGGAAGTGACAGAGGACGGTG 
R: GAGGCAAAGTGTTGACAAAGGG 
57 250 
lif NM008501 
F: TGGCAACGGGACAGAGAAGAC 
R: ACGGTACTTGTTGCACAGACGG 
58 202 
lifR NM013584 
F: CCAAGGACGGAACCAGTAGCAC 
R: GACGAAGGGTATTGCCGATCTG 
57 325 
gata3 NM008091 
F: CTGGAGGAGGAACGCTAATGG 
R: TGTGGCTGGAGTGGCTGAAG 
57 263 
 
Table 1. Primers and P R conditions for gene expression analysis 
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 mg DEHP/kg/day 
 0  0.05  5  
F1    
No. of oocytes 352 368 328 
Oocytes/animal 35.20 ± 3.1 36.80 ± 2.3 32.80 ± 5.1 
Cleavage rate (%) 74.2 ± 6.6 
a
 47.1 ± 7.3
 b
 74.2 ± 5.7
 a
 
Blastocyst rate (%) 64.4 ± 7.8
 a
 26.9 ± 9.8
 b
 57.1 ± 5.8
 a
 
Blastocyst/cleaved rate 
(%) 
77.7 ± 7.3
 a
 38.4 ± 9.9
 b
 77.5 ± 5.6
 a
 
F2    
No. of oocytes 412 324 304 
Oocytes/animal 30.71 ± 3.3 27.00 ± 3.4 30.40 ± 4.6 
Cleavage rate (%) 74.3 ± 4.8 
a
 53.2 ± 1.7
 b
 73.2 ± 9.5
 a
 
Blastocyst rate (%) 68.5 ± 6.4
 a
 32.9 ± 4.4
 b
 74.0 ± 6.3
 a
 
Blastocyst/cleaved rate 
(%) 
87.4 ± 1.1
 a
 59.2 ± 8.6
 b
 93.9 ± 3.8
 a
 
F3    
No. of oocytes 378 344 332 
Oocytes/animal 26.00 ± 1.9 28.00 ± 3.9 28.00 ± 2.3 
Cleavage rate (%) 82.8 ± 3.2 
a
 55.6 ± 6.2
 b
 84.4 ± 3.5
 a
 
Blastocyst rate (%) 75.9 ± 3.8
 a
 22.7 ± 6.7
 b
 65.6 ± 8.3
 a
 
Blastocyst/cleaved rate 
(%) 
87.8 ± 1.5
 a
 38.5 ± 11.5
 b
 77.4 ± 7.6
 a
 
Values are mean ± SEM. a, b: different superscripts in the same column indicate 
statistical differences for P ≤ 0.05. 
 
Table 2. Effects of pre- and perinatal DEHP exposure on developmental capacity of oocytes from 
F1, F2 and F3 offspring. 
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mg DEHP/kg/day 
0.05 5 
Gonadotropin response and steroidogenesis 
 
F1 F2 F3 F1 F2 F3 
Fsh-R 0.61 ± 0.1  
↓ 
1.1 ± 0.6 1.0 ± 0.1 0.67 ± 0.1 
 ↓ 
0.90 ± 0.9 1.20 ± 0.2 
Lh-R 0.66 ± 0.8   ↓ 1.08 ± 0.3 1.11 ± 0.2 0.64 ± 0.1 
 ↓ 
1.00 ± 0.4 1.13 ± 0.2 
StAR 0.93 ± 0.6 1.02 ± 0.8 1.02 ± 0.4 1.00 ± 0.8 1.20 ± 0.1 1.12 ± 0.6 
Cyp17a1 0.93 ± 0.7 1.01 ± 0.2 1.03 ± 0.3 0.64 ± 0.1 
 ↓ 
1.00 ± 0.1 1.06 ± 0.7 
Cyp19a1 0.69 ± 0.6   ↓ 1.06 ± 0.4 0.89 ± 0.9 0.72 ± 0.1 
 ↓ 
0.96 ± 0.4 1.01 ± 0.9 
Pgr 0.75 ±0.5 
↓ 
0.93 ± 0.7 0.94 ± 0.8 0.81 ± 0.4   ↓ 0.97 ± 0.1 0.98 ± 0.5 
Oocyte quality and folliculogenesis 
Bmp15 1.12 ± 0.5 0.99 ± 0.4 1.16 ± 0.1 0.99 ± 0.6 0.97 ± 0.3 1.22 ± 0.2 
Gdf9 1.43 ± 0.1 
 ↑ 
1.67 ± 0.2 ↑↑ 1.76 ± 0.9 
↑ 
2.11 ± 0.2 
↑↑ 
1.69 ± 0.2 
↑ 
1.99 ± 0.2 
↑↑ 
pTEN 0.93 ± 0.7 1.05 ± 0.1 1.02 ± 0.1 0.93 ± 0.5 1.09 ± 0.9 0.96 ± 0.2 
 
Table 3. Effects of pre- and perinatal DEHP exposure on expression profile of selected transcripts 
in ovaries from F1, F2 and F3 offspring. For each primer set each amplification run was performed 
on treatment groups and corresponding generation-control. Normalized data are expressed as 
DEHP/control ratio ± SEM (↑↑: P ≤ 0.001; ↑: P ≤ 0.05). 
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                                      mg DEHP/kg/day 
 0.05 5 
Embryonic development and trophoblast differentiation and implantation 
Embryonic 
generation F2 F3 F4 F2 F3 F4 
Oct-4 2.20 ± 0.8 
↑↑ 
2.26 ± 0.2 
↑↑ 
1.33 ± 0.9 
 
1.94 ± 0.1 
↑↑ 
1.92 ± 0.2 
↑↑ 
1.14 ± 0.2 
 
Nanog  0.78 ± 0.2   
↓↓ 
0.54 ± 0.1 
↓↓ 
1.05 ± 0.2 0.45 ± 0.1 
↓↓ 
0.83 ± 0.4 
↓ 
1.06 ± 0.2 
Gata-3 2.27 ± 0.3 
↑↑ 
2.34 ± 0.2 
↑↑ 
1.09 ± 0.3 1.91 ± 0.2 
↑↑ 
1.53 ± 0.2 
↑ 
0.98 ± 0.2 
Trophoblast differentiation and implantation 
Cdx-2 1.26 ± 0.2 
 
1.98 ± 0.2 
↑↑ 
4.04 ± 0.1 
↑↑ 
1.39 ± 0.3 
 
1.84 ± 0.2 
↑↑ 
7.71 ± 0.3 
↑↑ 
Eomes 1.20 ± 0.2 
 
2.89 ± 0.5 ↑↑ 2.47 ± 0.7 
↑↑ 
1.31 ± 0.2 
 
2.51 ± 0.7 
↑↑ 
2.54 ± 0.6 
↑↑ 
Lif  1.29 ± 0.2 2.53 ± 0.9 
↑↑ 
1.59 ± 0.1 
↑↑ 
0.98 ± 0.2 0.95 ± 0.1 1.28 ± 0.2 
Lif-R 1.51 ± 0.2   
↑ 
1.73 ± 0.2   
↑↑ 
0.73 ± 0.1 2.24 ± 0.2  
↑↑ 
2.23 ± 0.2 
↑↑ 
2.21 ± 0.2 
↑↑ 
 
Table 4. Effects of pre- and perinatal DEHP exposure on expression profile of selected transcripts 
in blastocysts derived from F1, F2 and F3 oocytes. For each primer set each amplification run was 
performed on treatment groups and corresponding generation-control. Normalized data are 
expressed as DEHP/control ratio ± SEM (↑↑: P ≤ 0.001; ↑: P ≤ 0.05). 
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HIGHLIGHTS 
 Maternal exposure to DEHP transgenerationally affects female reproductive health 
 DEHP reduced ovarian follicular reserve up to the third generation 
 DEHP reduced oocyte and blastocyst developmental competence up to F3 
 DEHP altered expression levels for key genes in ovary and blastocysts up to F4 
 DEHP’s adverse effects were observed at doses relevant for human exposure. 
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